[HTML][HTML] The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal …

L Mi, F Zhu, X Yang, J Lu, Y Zheng, Q Zhao, X Wen… - Oncogene, 2017 - nature.com
N-myc downstream-regulated gene 1 (NDRG1) has been reported to act as a key regulatory
molecule in tumor progression-related signaling pathways, especially in tumor metastasis …

[HTML][HTML] The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal …

L Mi, F Zhu, X Yang, J Lu, Y Zheng, Q Zhao, X Wen… - Oncogene, 2017 - ncbi.nlm.nih.gov
N-myc downstream-regulated gene 1 (NDRG1) has been reported to act as a key regulatory
molecule in tumor progression-related signaling pathways, especially in tumor metastasis …

The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal cancer …

L Mi, F Zhu, X Yang, J Lu, Y Zheng, Q Zhao, X Wen… - Oncogene, 2017 - europepmc.org
N-myc downstream-regulated gene 1 (NDRG1) has been reported to act as a key regulatory
molecule in tumor progression-related signaling pathways, especially in tumor metastasis …

The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal cancer …

L Mi, F Zhu, X Yang, J Lu, Y Zheng, Q Zhao… - …, 2017 - pubmed.ncbi.nlm.nih.gov
N-myc downstream-regulated gene 1 (NDRG1) has been reported to act as a key regulatory
molecule in tumor progression-related signaling pathways, especially in tumor metastasis …

The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal cancer …

L Mi, F Zhu, X Yang, J Lu, Y Zheng, Q Zhao, X Wen… - Oncogene, 2017 - go.gale.com
N-myc downstream-regulated gene 1 (NDRG1) has been reported to act as a key regulatory
molecule in tumor progression-related signaling pathways, especially in tumor metastasis …